Agency for Health Technology Assessment & Tariff System (Agencja Oceny Technologii Medycznych i Taryfikacji,AOTMiT),Warsaw,Poland.
Professor emerita,National Institute for Health and Welfare (THL),Helsinki,Finland.
Int J Technol Assess Health Care. 2017 Jan;33(3):331-332. doi: 10.1017/S0266462317000988.
The number of publications on health technology assessment (HTA) from Central, Eastern, and Southern Europe (CESE countries) is still low compared with the north and west of Europe. It is not surprising, as the idea of HTA originated from high-income Western economies and was afterward adopted by the south-eastern part of Europe, which mostly consists of middle-income countries. These CESE countries, with less capacity and experience with HTA processes, must deal with even tougher decisions on financing health technologies than north-western Europe. There may even be a lack of confidence to open discussions on their specific needs for HTA.
与欧洲北部和西部相比，来自中欧、东欧和南欧（CESE 国家）的卫生技术评估（HTA）出版物数量仍然较少。这并不奇怪，因为 HTA 的理念源自高收入的西方国家，后来被东南欧（主要由中等收入国家组成）采纳。这些 CESE 国家在 HTA 流程方面的能力和经验较少，因此必须比西北欧国家做出更艰难的健康技术融资决策。甚至可能缺乏信心就其 HTA 的具体需求展开讨论。
